Journal of Neuroimmunology
Volume 221, Issue 1 , Pages 15-24 , 15 April 2010

Effect of carbamylated erythropoietin on major histocompatibility complex expression and neural differentiation of human neural stem cells

  • Zhong-Qiu Fu

      Affiliations

    • Department of Pediatrics, The Second Affiliated Hospital, Harbin Medical University, Harbin 150000, China
    • ,
  • Qing-Liang Shao

      Affiliations

    • Department of Pediatrics, The Second Affiliated Hospital, Harbin Medical University, Harbin 150000, China
    • ,
  • Jing-Ling Shen

      Affiliations

    • Department of Histology and Embryology, Harbin Medical University, Harbin 150000, China
    • ,
  • Yu-Jing Zhang

      Affiliations

    • Department of Pediatrics, The Second Affiliated Hospital, Harbin Medical University, Harbin 150000, China
    • ,
  • Xia-Xia Zhao

      Affiliations

    • Department of Pediatrics, The Second Affiliated Hospital, Harbin Medical University, Harbin 150000, China
    • ,
  • Li Yao

      Affiliations

    • Department of Pediatrics, The Second Affiliated Hospital, Harbin Medical University, Harbin 150000, China
    • Corresponding Author InformationCorresponding author. Department of Pediatrics, The Second Affiliated Hospital, Harbin Medical University, No. 246 Xuefu Road, Nangang District, Harbin 150000, China. Tel.: +86 451 8660 5665.

Received 31 August 2009 ,Revised 13 January 2010 ,Accepted 25 January 2010.

References 

  1. Adembri C, Massagrande A, Tani A, Miranda M, Margheri M, De Gaudio R, et al. Carbamylated erythropoietin is neuroprotective in an experimental model of traumatic brain injury. Crit. Care Med. 2008;36:975–978
  2. Al Nimer F, Wennersten A, Holmin S, Meijer X, Wahlberg L, Mathiesen T. MHC expression after human neural stem cell transplantation to brain contused rats. Neuroreport. 2004;26:1871–1875
  3. Barker RA, Widner H. Immune problems in central nervous system cell therapy. Neuro. Rx. 2004;1:472–481
  4. Bowness P, Caplan S, Edidin M. MHC molecules lead many lives. Workshop on MHC class I molecules at the interface between biology & medicine. EMBO Rep. 2009;10:30–34
  5. Bradbury MS, Panagiotakos G, Chan BK, Tomishima M, Zanzonico P, Vider J, et al. Optical bioluminescence imaging of human ES cell progeny in the rodent CNS. J. Neurochem. 2007;102:2029–2039
  6. Cheng Y, King NJ, Kesson AM. Major histocompatibility complex class I (MHC-I) induction by West Nile virus: involvement of 2 signaling pathways in MHC-I up-regulation. J. Infect. Dis. 2004;189658–189668
  7. Digicaylioglu M, Lipton SA. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signaling cascades. Nature. 2001;412:641–647
  8. Duan WM, Westerman M, Flores T, Low WC. Survival of intrastriatal xenografts of ventral mesencephalic dopamine neurons from MHC-deficient mice to adult rats. Exp. Neurol. 2001;167:108–117
  9. Duan WM, Westerman MA, Wong G, Low WC. Rat nigral xenografts survive in the brain of MHC class II-, but not class I-deficient mice. Neuroscience. 2002;115:495–504
  10. Genc S, Koroglu TF, Genc K. Erythropoietin and the nervous system. Brain Res. 2004;12:19–31
  11. Goddard CA, Butts DA, Shatz CJ. Regulation of CNS synapses by neuronal MHC class I. Proc. Natl. Acad. Sci. U. S. A. 2007;104:6828–6833
  12. Haylett RS, Koch N, Rink L. MHC class II molecules activate NFAT and the ERK group of MAPK through distinct signaling pathways in B cells. Eur. J. Immunol. 2009;39:1947–1955
  13. Huh GS, Boulanger LM, Du H, Riquelme PA, Brotz TM, Shatz CJ. Functional requirement for class I MHC in CNS development and plasticity. Science. 2000;290:2155–2159
  14. Johansson S, Price J, Modo M. Effect of inflammatory cytokines on major histocompatibility complex expression and differentiation of human neural stem/progenitor cells. Stem Cells. 2008;26:2444–2454
  15. King VR, Averill SA, Hewazy D, Priestley JV, Torup L, Michael-Titus AT. Erythropoietin and carbamylated erythropoietin are neuroprotective following spinal cord hemisection in the rat. Eur. J. Neurosci. 2007;26:90–100
  16. Leist M, Ghezzi P, Grasso G, Bianchi R, Villa P, Fratelli M, et al. Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science. 2004;305:239–242
  17. Liao ZB, Zhi XG, Shi QH, He ZH. Recombinant human erythropoietin administration protects cortical neurons from traumatic brain injury in rats. Eur. J. Neurol. 2008;15:140–149
  18. Liu X, Ye L, Bai Y, Mojidi H, Simister NE, Zhu X. Activation of the JAK/STAT-1 signaling pathway by IFN-γ can down-regulate functional expression of the MHC class I-related neonatal Fc receptor for IgG. J. Immunol. 2008;181:449–463
  19. Moretta L, Bottino C, Cantoni C, Mingari MC, Moretta A. Human natural killer cell function and receptors. Curr. Opin. Pharmacol. 2001;1:387–391
  20. Oliveira AL, Thams S, Lidman O, Piehl F, Hokfelt T, Karre K, et al. A role for MHC class I molecules in synaptic plasticity and regeneration of neurons after axotomy. Proc. Natl. Acad. Sci. U. S. A. 2004;101:17843–17848
  21. Sanchez PE, Navarro FP, Fares RP, Nadam J, Georges B, Moulin C, et al. Erythropoietin receptor expression is concordant with erythropoietin but not with common beta chain expression in the rat brain throughout the life span. J. Comp. Neurol. 2009;514:403–414
  22. Savino C, Pedotti R, Baggi F, Ubiali F, Gallo B, Nava S, et al. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis. J. Neuroimmunol. 2006;172:27–37
  23. Schmidt RE, Green KG, Feng D, Dorsey DA, Parvin CA, Lee JM, et al. Erythropoietin and its carbamylated derivative prevent the development of experimental diabetic autonomic neuropathy in STZ-induced diabetic NOD-SCID mice. Exp. Neurol. 2008;209:161–170
  24. Sirén AL, Fratelli M, Brines M, Goemans C, Casagrande S, Lewczuk P, et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc. Natl. Acad. Sci. U. S. A. 2001;98:4044–4049
  25. Sirén AL, Fasshauer T, Bartels C, Ehrenreich H. Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics. 2009;6:108–127
  26. Stampachiacchiere B, Aloe L. Differential modulatory effect of NGF on MHC class I and class II expression in spinal cord cells of EAE rats. J. Neuroimmunol. 2005;169:20–30
  27. Villa P, van Beek J, Larsen AK, Gerwien J, Christensen S, Cerami A, et al. Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives. J. Cereb. Blood Flow Metab. 2007;25:52–63
  28. Wang L, Zhang ZG, Gregg SR, Zhang RL, Jiao Z, LeTourneau Y, et al. The Sonic hedgehog pathway mediates carbamylated erythropoietin-enhanced proliferation and differentiation of adult neural progenitor cells. J. Biol. Chem. 2007;2:32462–32470
  29. Wennersten A, Holmin S, Al Nimer F, Meijer X, Wahlberg LU, Mathiesen T. Sustained survival of xenografted human neural stem/progenitor cells in experimental brain trauma despite discontinuation of immunosuppression. Exp. Neurol. 2006;199:339–347
  30. Yiş U, Kurul SH, Kumral A, Tuğyan K, Cilaker S, Yilmaz O, et al. Effect of erythropoietin on oxygen-induced brain injury in the newborn rat. Neurosci. Lett. 2008;448:245–249
  31. Yoshimura S, Bondeson J, Foxwell BM, Brennan FM, Feldmann M. Effective antigen presentation by dendritic cells is NF-κB dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokines. Int. Immunol. 2001;13:675–683

PII: S0165-5728(10)00037-8

doi: 10.1016/j.jneuroim.2010.01.016

Journal of Neuroimmunology
Volume 221, Issue 1 , Pages 15-24 , 15 April 2010

Article Tools

* Image Usage & Resolution